Suzanne Trudel, MD¹, Adam D Cohen², Amrita Y. Krishnan, MD³, Rafael Fonseca⁴, Andrew Spencer⁵, Jesús G. Berdeja⁶, Alexander Lesokhin, MD⁷, Peter A Forsberg⁸, Jacob P. Laubach^9*, Luciano J. Costa, MD, PhD¹⁰, Paula Rodriguez-Otero^11*, Rayan Kaedbey¹², Joshua Richter, MD¹³, Maria-Victoria Mateos¹⁴, Sheeba K Thomas, MD, MS¹⁵, Chihunt Wong^16*, Mengsong Li^16*, Voleak Choeurng^16*, Anjali Vaze^16*, Divya Samineni^16*, Teiko Sumiyoshi^16*, James Cooper^16* and Simon J Harrison, MD¹⁷

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³City of Hope, Duarte, CA
⁴Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
⁵Alfred Health-Monash University, Melbourne, VIC, Australia
⁶Sarah Cannon Research Institute, Nashville, TN
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸University of Colorado School of Medicine, Aurora, CO
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰University of Alabama at Birmingham, Vestavia, AL
¹¹Clínica Universidad de Navarra, Pamplona, Spain
¹²Jewish General Hospital, McGill University, Montreal, QC, Canada
¹³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁴Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
¹⁵The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Genentech, Inc., South San Francisco, CA
¹⁷Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, Melbourne University, and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Amrita Y. Krishnan, MD¹, Monique C. Minnema, MD², Jesús G. Berdeja³, Albert Oriol^4*, Niels W.C.J. van de Donk⁵, Paula Rodriguez-Otero^6*, Elham Askari^7*, Maria-Victoria Mateos⁸, Luciano J. Costa, MD, PhD⁹, Raluca I. Verona^10*, Xuewen Ma^10*, Suzette Girgis¹⁰, Shiyi Yang^10*, Brandi W. Hilder^10*, Jeffery Russell^10*, Jenna D. Goldberg^11* and Ajai Chari, MD^12*

¹City of Hope Comprehensive Cancer Center, Duarte, CA
²University Medical Center Utrecht, Utrecht, Netherlands
³Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
⁴Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
⁵Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Spain
⁶Clínica Universidad de Navarra, Navarra, Spain
⁷Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
⁸University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
⁹University of Alabama at Birmingham, Birmingham, AL
¹⁰Janssen Research & Development, Spring House, PA
¹¹Janssen Research & Development, Raritan, NJ
¹²Mount Sinai School of Medicine, New York, NY

Raymond Comenzo, MD¹, Giovanni Palladini², Efstathios Kastritis^3*, Monique C. Minnema, MD⁴, Ashutosh D. Wechalekar^5*, Arnaud Jaccard^6*, Angela Dispenzieri, MD⁷, Hans C. Lee, MD⁸, Vaishali Sanchorawala, MD⁹, Simon D. Gibbs^10*, Peter Mollee¹¹, Chris P. Venner¹², Jin Lu, MD¹³, Stefan Schönland^14*, Moshe Gatt¹⁵, Kenshi Suzuki, MD, PhD¹⁶, Kihyun Kim^17*, M. Teresa Cibeira^18*, Meral Beksac^19*, Edward Libby²⁰, Jason Valent²¹, Vania Hungria²², Sandy W. Wong, MD²³, Michael Rosenzweig²⁴, Naresh Bumma²⁵, NamPhuong Tran^26*, Xiang Qin^27*, Samer Khaled^28*, Jessica Vermeulen²⁹ and Giampaolo Merlini^2*

¹Tufts Medical Center, Boston, MA
²Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁵University College London, London, United Kingdom
⁶Centre Hospitalier Universitaire and Reference Center for AL Amyloidosis, Limoge, France
⁷Mayo Clinic, Rochester, MN
⁸Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Medicine and Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA
¹⁰The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Easter Health Clinical School, Melbourne, VIC, Australia
¹¹Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
¹²University of Alberta, Edmonton, AB, Canada
¹³Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing, China
¹⁴Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
¹⁵Hematology Department, Hadassah Hebrew University Medical Center, Jerusalem, Israel
¹⁶Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
¹⁷Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹⁸Amyloidosis and Myeloma Unit, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
¹⁹Department of Hematology, Ankara University, Ankara, Turkey
²⁰Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
²¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²²Clinica São Germano, São Paulo, Brazil
²³Department of Medicine, University of California San Francisco, San Francisco, CA
²⁴Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²⁵Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
²⁶Janssen Research & Development, LLC, Los Angeles, CA
²⁷Janssen Research & Development, Spring House, PA
²⁸Janssen Research & Development, Los Angeles, CA
²⁹Janssen Research & Development, Leiden, CB, Netherlands

Jeffrey A. Zonder, MD ¹, Joshua Richter, MD², Naresh Bumma³, Jason Brayer, PhD, MD⁴, James E Hoffman, MD⁵, William I. Bensinger, MD^6*, Ka Lung Wu, MD⁷, Linzhi Xu, PhD^8*, Dhruti Chokshi, BS^9*, Anita Boyapati, PhD^10*, Manish Sharma, MD^9*, Karen Rodriguez Lorenc, MD¹¹, Glenn S Kroog, MD^9*, Madhav V Dhodapkar, MD¹², Suzanne Lentzsch, MD, PhD^13*, Dennis Cooper, MD¹⁴ and Sundar Jagannath, MD^2*

¹Karmanos Cancer Institute, Detroit, MI
²Icahn School of Medicine at Mount Sinai, New York, NY
³The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁴H. Lee Moffitt Cancer Center, Tampa, FL
⁵University of Miami Health System, Miami, FL
⁶Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
⁷Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium
⁸Biostatistics and Data Management, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁹Clinical Sciences, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹⁰Precision Medicine, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹¹Program Direction, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹²Emory University School of Medicine, Atlanta, GA
¹³Columbia University Medical Center, New York, NY
¹⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Ajai Chari, MD^1*, Parameswaran Hari², Nizar J. Bahlis, MD³, Maria-Victoria Mateos⁴, Niels W.C.J. van de Donk⁵, Bhagirathbhai Dholaria, MBBS⁶, Alfred L. Garfall^7*, Hartmut Goldschmidt⁸, K. Martin Kortuem^9*, Amrita Y. Krishnan, MD¹⁰, Thomas Martin, MD¹¹, Daniel Morillo Giles^12*, Albert Oriol^13*, Donna E. Reece¹⁴, Cesar Rodriguez¹⁵, Paula Rodriguez-Otero^16*, Jesús F. San-Miguel¹⁶, Saad Z. Usmani, MD MBA FACP¹⁷, Raluca I. Verona^18*, Shun Xin Wang Lin^18*, Thomas J. Prior^18*, Mark Wade^18*, Brendan M. Weiss¹⁸, Jenna D. Goldberg^19* and Elham Askari^12*

¹Mount Sinai School of Medicine, New York, NY
²Medical College of Wisconsin, Milwaukee, WI
³Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁴University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
⁵Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁶Vanderbilt University Medical Center, Nashville, TN
⁷Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁸University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases (NCT), Heidelberg, Germany
⁹University Hospital Wuerzburg, Wuerzburg, Germany
¹⁰City of Hope Comprehensive Cancer Center, Duarte, CA
¹¹University of California San Francisco, San Francisco, CA
¹²Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹³Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁵Wake Forest University School of Medicine, Winston-Salem, NC
¹⁶Clinica Universidad de Navarra, Navarra, Spain
¹⁷Levine Cancer Institute/Atrium Health, Charlotte, NC
¹⁸Janssen Research & Development, Spring House, PA
¹⁹Janssen Research & Development, Raritan, NJ

Sagar Lonial, MD, FACP¹, Rakesh Popat, MBBS, FRCPath, PhD^2*, Cyrille Hulin^3*, Sundar Jagannath, MD^4*, Albert Oriol^5*, Paul G. Richardson, MD⁶, Thierry Facon^7*, Katja Weisel^8*, Jeremy T. Larsen⁹, Monique C. Minnema, MD¹⁰, Al-Ola Abdallah, MD¹¹, Ashraf Z. Badros, MD¹², Stefan Knop^13*, Edward A. Stadtmauer^14*, Min Chen^15*, Tuong Vi Nguyen^15*, Alpesh Amin^15*, Elisabeth Kueenburg^16*, Teresa Peluso^16* and Niels W.C.J. van de Donk¹⁷

¹Winship Cancer Institute, Emory University, Atlanta, GA
²NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
³Service d'Hématologie Hôpital Haut-Lévêque, CHU Bordeaux, Pessac, France
⁴The Mount Sinai Hospital, New York, NY
⁵Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Service des Maladies du Sang, CHRU de Lille - Hôpital Claude Huriez, Lille, France
⁸University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹Mayo Clinic Arizona, Phoenix, AZ
¹⁰University Medical Center Utrecht, Utrecht, Netherlands
¹¹University of Kansas Medical Center, Kansas City, KS
¹²Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
¹³Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
¹⁴University of Pennsylvania, Philadelphia, PA
¹⁵Bristol Myers Squibb, Princeton, NJ
¹⁶Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁷Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands